April 2024
1. XIANG J, Liu B, Li Y, Ren Y, et al
   TFEB regulates dendritic cell antigen presentation to modulate immune balance in asthma.
   Respir Res. 2024;25:182.
   

   >> Share

   
   
2. FARINHA I, Heaney LG
   Barriers to clinical remission in severe asthma.
   Respir Res. 2024;25:178.
   

   >> Share

   
   
3. PINKERTON JW, Preite S, Piras A, Zervas D, et al
   PI3Kgammadelta inhibition suppresses key disease features in a rat model of asthma.
   Respir Res. 2024;25:175.
   

   >> Share

   
   
4. WAN R, Srikaram P, Xie S, Chen Q, et al
   PPARgamma attenuates cellular senescence of alveolar macrophages in asthma-COPD overlap.
   Respir Res. 2024;25:174.
   

   >> Share

   
   
5. XIAO W, Chen YL, Du LY, Wu J, et al
   Bacterial interactome disturbance in chronic obstructive pulmonary disease clinical stability and exacerbations.
   Respir Res. 2024;25:173.
   

   >> Share

   
   
6. LIU Y, Chen F, Zeng Z, Lei C, et al
   Neopterin in patients with COPD, asthma, and ACO: association with endothelial and lung functions.
   Respir Res. 2024;25:171.
   

   >> Share

   
   
7. ZHU Z, Zhao S, Li J, Wang Y, et al
   Development and application of a deep learning-based comprehensive early diagnostic model for chronic obstructive pulmonary disease.
   Respir Res. 2024;25:167.
   

   >> Share

   
   
8. GAO J, Yang Y, Xiang X, Zheng H, et al
   Human genetic associations of the airway microbiome in chronic obstructive pulmonary disease.
   Respir Res. 2024;25:165.
   

   >> Share

   
   
9. KOVACH MA, Kack U, Che KF, Brundin B, et al
   Systemic IL-26 correlates with improved asthma control in children sensitized to dog allergen.
   Respir Res. 2024;25:163.
   

   >> Share

   
   
10. FUNG NH, Nguyen QA, Owczarek C, Wilson N, et al
    Early-life house dust mite aeroallergen exposure augments cigarette smoke-induced myeloid inflammation and emphysema in mice.
    Respir Res. 2024;25:161.
    

    >> Share

    
    
11. DING Y, Wang Z, Zhang Z, You R, et al
    GLUT3-mediated cigarette smoke-induced epithelial-mesenchymal transition in chronic obstructive pulmonary disease through the NF-kB/ZEB1 pathway.
    Respir Res. 2024;25:158.
    

    >> Share

    
    March 2024
12. BERGWIK J, Liu J, Padra M, Bhongir RKV, et al
    A novel quinoline with airway relaxant effects and anti-inflammatory properties.
    Respir Res. 2024;25:146.
    

    >> Share

    
    
13. KIM T, Shin SH, Kim H, Im Y, et al
    Longitudinal BMI change and outcomes in Chronic Obstructive Pulmonary Disease: a nationwide population-based cohort study.
    Respir Res. 2024;25:150.
    

    >> Share

    
    
14. DING H, Yan L, Wang Y, Lu Y, et al
    Astaxanthin attenuates cigarette smoke-induced small airway remodeling via the AKT1 signaling pathway.
    Respir Res. 2024;25:148.
    

    >> Share

    
    
15. LU L, Wu F, Peng J, Wu X, et al
    Clinical characterization and outcomes of impulse oscillometry-defined bronchodilator response: an ECOPD cohort-based study.
    Respir Res. 2024;25:149.
    

    >> Share

    
    
16. WU J, Meng W, Ma Y, Zhao Z, et al
    Early smoking lead to worse prognosis of COPD patients: a real world study.
    Respir Res. 2024;25:140.
    

    >> Share

    
    
17. HSU YT, Wu CC, Wang CC, Sheu CC, et al
    Increased di-(2-ethylhexyl) phthalate exposure poses a differential risk for adult asthma clusters.
    Respir Res. 2024;25:139.
    

    >> Share

    
    
18. MEI S, Li D, Wang A, Zhu G, et al
    The role of sialidase Neu1 in respiratory diseases.
    Respir Res. 2024;25:134.
    

    >> Share

    
    
19. SHIN SH, Kim T, Kim H, Cho J, et al
    Impact of smoking reduction on lung cancer risk in patients with COPD who smoked fewer than 30 pack-years: a nationwide population-based cohort study.
    Respir Res. 2024;25:133.
    

    >> Share

    
    
20. MCCLUSKEY ES, Liu N, Pandey A, Marchetti N, et al
    Quercetin improves epithelial regeneration from airway basal cells of COPD patients.
    Respir Res. 2024;25:120.
    

    >> Share

    
    
21. HONG X, Jiang M, Kho AT, Tiwari A, et al
    Circulating miRNAs associate with historical childhood asthma hospitalization in different serum vitamin D groups.
    Respir Res. 2024;25:118.
    

    >> Share

    
    
22. CAI R, Gong X, Li X, Jiang Y, et al
    Dectin-1 aggravates neutrophil inflammation through caspase-11/4-mediated macrophage pyroptosis in asthma.
    Respir Res. 2024;25:119.
    

    >> Share

    
    
23. LAN G, Xie M, Lan J, Huang Z, et al
    Association and mediation between educational attainment and respiratory diseases: a Mendelian randomization study.
    Respir Res. 2024;25:115.
    

    >> Share

    
    
24. WU Y, He B, Hua J, Hu W, et al
    Deciphering the molecular regulatory of RAB32/GPRC5A axis in chronic obstructive pulmonary disease.
    Respir Res. 2024;25:116.
    

    >> Share

    
    February 2024
25. MATERA MG, Rinaldi B, Calabrese C, Belardo C, et al
    The effect of combining an inhaled corticosteroid and a long-acting muscarinic antagonist on human airway epithelial cells in vitro.
    Respir Res. 2024;25:104.
    

    >> Share

    
    
26. BELL AJ, Pal R, Labaki WW, Hoff BA, et al
    Local heterogeneity of normal lung parenchyma and small airways disease are associated with COPD severity and progression.
    Respir Res. 2024;25:106.
    

    >> Share

    
    
27. SIROUX V, Boudier A, Lyon-Caen S, Quentin J, et al
    Intra-breath changes in respiratory mechanics are sensitive to history of respiratory illness in preschool children: the SEPAGES cohort.
    Respir Res. 2024;25:99.
    

    >> Share

    
    
28. CHANG C, Huang K, Xu X, Duan R, et al
    MiR-23a-5p alleviates chronic obstructive pulmonary disease through targeted regulation of RAGE-ROS pathway.
    Respir Res. 2024;25:93.
    

    >> Share

    
    
29. TU J, Wen J, Luo Q, Li X, et al
    Causal relationships of metabolites with allergic diseases: a trans-ethnic Mendelian randomization study.
    Respir Res. 2024;25:94.
    

    >> Share

    
    
30. SUN J, Deng YP, Xu J, Zhu FM, et al
    Association of blood cadmium concentration with chronic obstructive pulmonary disease progression: a prospective cohort study.
    Respir Res. 2024;25:91.
    

    >> Share

    
    
31. ZHANG J, Yi Q, Zhou C, Luo Y, et al
    A simple clinical risk score (ABCDMP) for predicting mortality in patients with AECOPD and cardiovascular diseases.
    Respir Res. 2024;25:89.
    

    >> Share

    
    
32. GAO J, Um-Bergstrom P, Pourbazargan M, Berggren-Brostrom E, et al
    Large airway T cells in adults with former bronchopulmonary dysplasia.
    Respir Res. 2024;25:86.
    

    >> Share

    
    
33. LU T, Lahousse L, Wijnant S, Chen J, et al
    The AGE-RAGE axis associates with chronic pulmonary diseases and smoking in the Rotterdam study.
    Respir Res. 2024;25:85.
    

    >> Share

    
    
34. LIU S, Tan X, Liu S
    The role of extracellular vesicles in COPD and potential clinical value.
    Respir Res. 2024;25:84.
    

    >> Share

    
    
35. WU W, Li J, Chen S, Ouyang S, et al
    The airway neuro-immune axis as a therapeutic target in allergic airway diseases.
    Respir Res. 2024;25:83.
    

    >> Share

    
    
36. GAYEN SK, Zulty M, Criner GJ
    Elevated pulmonary vascular resistance is associated with increased lung transplant waitlist mortality among patients with chronic obstructive pulmonary disease and pulmonary hypertension: a retrospective cohort analysis.
    Respir Res. 2024;25:79.
    

    >> Share

    
    
37. YU X, Li L, Cai B, Zhang W, et al
    Single-cell analysis reveals alterations in cellular composition and cell-cell communication associated with airway inflammation and remodeling in asthma.
    Respir Res. 2024;25:76.
    

    >> Share

    
    
38. ZHANG Q, Yan L, Lu Y, Liu X, et al
    HDAC6-selective inhibitor CAY10603 ameliorates cigarette smoke-induced small airway remodeling by regulating epithelial barrier dysfunction and reversing.
    Respir Res. 2024;25:66.
    

    >> Share

    
    
39. LU F, Yao LP, Gao DD, Alinejad T, et al
    MicroRNA-377-3p exacerbates chronic obstructive pulmonary disease through suppressing ZFP36L1 expression and inducing lung fibroblast senescence.
    Respir Res. 2024;25:67.
    

    >> Share

    
    
40. CHANG YP, Tsai YH, Chen YM, Huang KT, et al
    Upregulated microRNA-125b-5p in patients with asthma-COPD overlap mediates oxidative stress and late apoptosis via targeting IL6R/TRIAP1 signaling.
    Respir Res. 2024;25:64.
    

    >> Share

    
    January 2024
41. FAHNDRICH S, Herr C, Teuteberg S, Alter P, et al
    Midregional proatrial naturetic peptide (MRproANP) and copeptin (COPAVP) as predictors of all-cause mortality in recently diagnosed mild to moderate COPD-results from COSYCONET.
    Respir Res. 2024;25:56.
    

    >> Share

    
    
42. AUDOUSSET C, Swaleh S, Olivenstein R, Vameghestahbanati M, et al
    Mucus plugs in the airways of asthmatic subjects and smoking status.
    Respir Res. 2024;25:52.
    

    >> Share

    
    
43. UPADHYAY S, Rahman M, Rinaldi S, Koelmel J, et al
    Assessment of wood smoke induced pulmonary toxicity in normal- and chronic bronchitis-like bronchial and alveolar lung mucosa models at air-liquid interface.
    Respir Res. 2024;25:49.
    

    >> Share

    
    
44. CHENG ZJ, Wu H, Chang Z, Cheng J, et al
    The genetic etiology of body fluids on chronic obstructive airways disease.
    Respir Res. 2024;25:46.
    

    >> Share

    
    
45. WELLS AU, Jacob J, Sverzellati N, Cross G, et al
    A formula for predicting emphysema extent in combined idiopathic pulmonary fibrosis and emphysema.
    Respir Res. 2024;25:33.
    

    >> Share

    
    
46. ZOLLER D, Haverkamp C, Makoudjou A, Sofack G, et al
    Alpha-1-antitrypsin-deficiency is associated with lower cardiovascular risk: an approach based on federated learning.
    Respir Res. 2024;25:38.
    

    >> Share

    
    
47. KWOK WC, Tam TCC, Ho JCM, Lam DCL, et al
    Hospitalized acute exacerbation in chronic obstructive pulmonary disease - impact on long-term renal outcomes.
    Respir Res. 2024;25:36.
    

    >> Share

    
    
48. WHITTAKER HR, Torkpour A, Quint J
    Eligibility of patients with chronic obstructive pulmonary disease for inclusion in randomised control trials investigating triple therapy: a study using routinely collected data.
    Respir Res. 2024;25:43.
    

    >> Share

    
    
49. WARE SA, Kliment CR, Giordano L, Redding KM, et al
    Cell-free DNA levels associate with COPD exacerbations and mortality.
    Respir Res. 2024;25:42.
    

    >> Share

    
    
50. REUTER S, Raspe J, Taube C
    Microbes little helpers and suppliers for therapeutic asthma approaches.
    Respir Res. 2024;25:29.
    

    >> Share

    
    
51. LI Z, Cheng T, Guo Y, Gao R, et al
    CD147 induces asthmatic airway remodeling and activation of circulating fibrocytes in a mouse model of asthma.
    Respir Res. 2024;25:6.
    

    >> Share

    
    
52. COOK S, Buskiewicz J, Levy DT, Meza R, et al
    Association between cigar use, with and without cigarettes, and incident diagnosed COPD: a longitudinal cohort study.
    Respir Res. 2024;25:13.
    

    >> Share

    
    
53. DETSIKA MG, Palamaris K, Dimopoulou I, Kotanidou A, et al
    The complement cascade in lung injury and disease.
    Respir Res. 2024;25:20.
    

    >> Share

    
    
54. DEDONDER J, Gelgon C, Guerder A, Nion N, et al
    "In their own words": delineating the contours of dyspnea invisibility in patients with advanced chronic obstructive pulmonary disease from quantitative discourse analysis.
    Respir Res. 2024;25:21.
    

    >> Share

    
    
55. PENG W, Xia Q, Zhang Y, Cao D, et al
    VEGF and EGFR signaling pathways are involved in the baicalein attenuation of OVA-induced airway inflammation and airway remodeling in mice.
    Respir Res. 2024;25:10.
    

    >> Share

    
    
56. FANG ZF, Wang ZN, Chen Z, Peng Y, et al
    Fine particulate matter contributes to COPD-like pathophysiology: experimental evidence from rats exposed to diesel exhaust particles.
    Respir Res. 2024;25:14.
    

    >> Share

    
    December 2023
57. LI C, Liu Q, Chang Q, Xie M, et al
    Role of mitochondrial fusion proteins MFN2 and OPA1 on lung cellular senescence in chronic obstructive pulmonary disease.
    Respir Res. 2023;24:319.
    

    >> Share

    
    
58. LOPEZ K, Li H, Lipkin-Moore Z, Kay S, et al
    Deep learning prediction of hospital readmissions for asthma and COPD.
    Respir Res. 2023;24:311.
    

    >> Share

    
    
59. EL-HUSSEINI ZW, Khalenkow D, Lan A, van der Molen T, et al
    An epithelial gene signature of trans-IL-6 signaling defines a subgroup of type 2-low asthma.
    Respir Res. 2023;24:308.
    

    >> Share

    
    
60. AKENROYE A, Nopsopon T, Cho L, Moll M, et al
    Lower myostatin and higher MUC1 levels are associated with better response to mepolizumab and omalizumab in asthma: a protein-protein interaction analyses.
    Respir Res. 2023;24:305.
    

    >> Share

    
    
61. HORVAT JC, Kim RY, Weaver N, Augood C, et al
    Characterization and inhibition of inflammasome responses in severe and non-severe asthma.
    Respir Res. 2023;24:303.
    

    >> Share

    
    
62. HWANG H, Jang JH, Lee E, Park HS, et al
    Prediction of the number of asthma patients using environmental factors based on deep learning algorithms.
    Respir Res. 2023;24:302.
    

    >> Share

    
    
63. LI C, Chen F, Lin L, Li J, et al
    CSE triggers ferroptosis via SIRT4-mediated GNPAT deacetylation in the pathogenesis of COPD.
    Respir Res. 2023;24:301.
    

    >> Share

    
    November 2023
64. CHEN B, Liu Z, Lu J, Li Z, et al
    Deep learning parametric response mapping from inspiratory chest CT scans: a new approach for small airway disease screening.
    Respir Res. 2023;24:299.
    

    >> Share

    
    
65. ZHU W, Han L, Wu Y, Tong L, et al
    Keratin 15 protects against cigarette smoke-induced epithelial mesenchymal transformation by MMP-9.
    Respir Res. 2023;24:297.
    

    >> Share

    
    
66. KANSAL H, Chopra V, Garg K, Sharma S, et al
    Role of thioredoxin in chronic obstructive pulmonary disease (COPD): a promising future target.
    Respir Res. 2023;24:295.
    

    >> Share

    
    
67. GAGNON PA, Klein M, De Vos J, Biardel S, et al
    S100A alarmins and thymic stromal lymphopoietin (TSLP) regulation in severe asthma following bronchial thermoplasty.
    Respir Res. 2023;24:294.
    

    >> Share

    
    
68. SWART KMA, Baak BN, Lemmens L, Penning-van Beest FJA, et al
    Risk of cardiovascular events after an exacerbation of chronic obstructive pulmonary disease: results from the EXACOS-CV cohort study using the PHARMO Data Network in the Netherlands.
    Respir Res. 2023;24:293.
    

    >> Share

    
    
69. CRAPO JD, Gupta A, Lynch DA, Turner AM, et al
    Baseline characteristics from a 3-year longitudinal study to phenotype subjects with COPD: the FOOTPRINTS study.
    Respir Res. 2023;24:290.
    

    >> Share

    
    
70. VAN DER SAR IG, Wijsenbeek MS, Braunstahl GJ, Loekabino JO, et al
    Differentiating interstitial lung diseases from other respiratory diseases using electronic nose technology.
    Respir Res. 2023;24:271.
    

    >> Share

    
    
71. TEE JH, Vijayakumar U, Shanmugasundaram M, Lam TYW, et al
    Isthmin-1 attenuates allergic Asthma by stimulating adiponectin expression and alveolar macrophage efferocytosis in mice.
    Respir Res. 2023;24:269.
    

    >> Share

    
    
72. CHOI B, San Jose Estepar R, Godbole S, Curtis JL, et al
    Plasma metabolomics and quantitative interstitial abnormalities in ever-smokers.
    Respir Res. 2023;24:265.
    

    >> Share

    
    
73. YI XZ, Yang JH, Huang Y, Han XR, et al
    Differential airway resistome and its correlations with clinical characteristics in Haemophilus- or Pseudomonas-predominant microbial subtypes of bronchiectasis.
    Respir Res. 2023;24:264.
    

    >> Share

    
    October 2023
74. HEMPEL P, Klein V, Michely A, Boll S, et al
    Amitriptyline inhibits bronchoconstriction and directly promotes dilatation of the airways.
    Respir Res. 2023;24:262.
    

    >> Share

    
    
75. CHANG C, Chen G, Wu W, Chen D, et al
    Exogenous IL-25 ameliorates airway neutrophilia via suppressing macrophage M1 polarization and the expression of IL-12 and IL-23 in asthma.
    Respir Res. 2023;24:260.
    

    >> Share

    
    
76. WERDECKER C, Bals R
    Impact of the COVID-19 pandemic on well-being and quality of life of patients with alpha-1-antitrypsin deficiency.
    Respir Res. 2023;24:258.
    

    >> Share

    
    
77. LIU L, Zhou L, Wang L, Mao Z, et al
    MUC1 attenuates neutrophilic airway inflammation in asthma by reducing NLRP3 inflammasome-mediated pyroptosis through the inhibition of the TLR4/MyD88/NF-kappaB pathway.
    Respir Res. 2023;24:255.
    

    >> Share

    
    
78. YASUDA Y, Wang L, Chitano P, Seow CY, et al
    Critical roles of airway smooth muscle in mediating deep-inspiration-induced bronchodilation: a big stretch?
    Respir Res. 2023;24:250.
    

    >> Share

    
    
79. SKLOOT GS, Guasconi A, Lavon BR, Georges G, et al
    The effect of inhaled extrafine beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide on distal and central airway indices, assessed using Functional Respiratory Imaging in COPD (DARWiIN).
    Respir Res. 2023;24:244.
    

    >> Share

    
    
80. BRETTONI C, Muzzi A, Rondini S, Weynants V, et al
    Ex-vivo RNA expression analysis of vaccine candidate genes in COPD sputum samples.
    Respir Res. 2023;24:243.
    

    >> Share

    
    September 2023
81. CHEN CY, Pan SW, Hsu CC, Liu JJ, et al
    Comparative cardiovascular safety of LABA/LAMA FDC versus LABA/ICS FDC in patients with chronic obstructive pulmonary disease: a population-based cohort study with a target trial emulation framework.
    Respir Res. 2023;24:239.
    

    >> Share

    
    
82. SPECTOR C, De Sanctis CM, Panettieri RA Jr, Koziol-White CJ, et al
    Rhinovirus induces airway remodeling: what are the physiological consequences?
    Respir Res. 2023;24:238.
    

    >> Share

    
    
83. PADILLA-GALO A, Moya Carmona I, Ausin P, Carazo Fernandez L, et al
    Achieving clinical outcomes with benralizumab in severe eosinophilic asthma patients in a real-world setting: orbe II study.
    Respir Res. 2023;24:235.
    

    >> Share

    
    
84. RONN C, Kamstrup P, Eklof J, Toennesen LL, et al
    Mortality and exacerbations associated with Stenotrophomonas maltophilia in chronic obstructive pulmonary disease. A regional cohort study of 22,689 outpatients.
    Respir Res. 2023;24:232.
    

    >> Share

    
    
85. SHEN K, Zhang M, Zhao R, Li Y, et al
    Eosinophil extracellular traps in asthma: implications for pathogenesis and therapy.
    Respir Res. 2023;24:231.
    

    >> Share

    
    
86. USMANI O, Li G, De Backer J, Sadafi H, et al
    Modeled small airways lung deposition of two fixed-dose triple therapy combinations assessed with in silico functional respiratory imaging.
    Respir Res. 2023;24:226.
    

    >> Share

    
    
87. KARAKIOULAKI M, Berkemeier CM, Heijnen I, Grize L, et al
    Staphylococcus aureus enterotoxin A- and B-specific IgE in chronic obstructive pulmonary disease.
    Respir Res. 2023;24:225.
    

    >> Share

    
    
88. ZOU RH, Nouraie SM, Karoleski C, Zhang Y, et al
    Incident low muscle mass is associated with greater lung disease and lower circulating leptin in a tobacco-exposed longitudinal cohort.
    Respir Res. 2023;24:224.
    

    >> Share

    
    
89. DEY S, Lu W, Haug G, Chia C, et al
    Airway inflammatory changes in the lungs of patients with asthma-COPD overlap (ACO): a bronchoscopy endobronchial biopsy study.
    Respir Res. 2023;24:221.
    

    >> Share

    
    
90. LIU J, Chen Y, Chen H, Wang Y, et al
    Macrophage migration inhibitory factor exacerbates asthmatic airway remodeling via dynamin-related protein 1-mediated autophagy activation.
    Respir Res. 2023;24:216.
    

    >> Share

    
    August 2023
91. YAO X, Chen Q, Wang X, Liu X, et al
    IL-25 induces airway remodeling in asthma by orchestrating the phenotypic changes of epithelial cell and fibrocyte.
    Respir Res. 2023;24:212.
    

    >> Share

    
    
92. TAKEUCHI H, Hasan SMT, Zaman K, Takanashi S, et al
    Correction to: Impact of Haemophilus influenzae type b combination vaccination on asthma symptoms and pneumonia in 5-year-old children in rural Bangladesh: a longitudinal study and comparison with a previous cross-sectional study.
    Respir Res. 2023;24:210.
    

    >> Share

    
    
93. ELSHOF J, Vonk JM, van der Pouw A, van Dijk C, et al
    Clinical practice of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease.
    Respir Res. 2023;24:208.
    

    >> Share

    
    
94. WANG Y, Ninaber DK, Faiz A, van der Linden AC, et al
    Acute cigarette smoke exposure leads to higher viral infection in human bronchial epithelial cultures by altering interferon, glycolysis and GDF15-related pathways.
    Respir Res. 2023;24:207.
    

    >> Share

    
    
95. DY ABC, Girkin J, Marrocco A, Collison A, et al
    Rhinovirus infection induces secretion of endothelin-1 from airway epithelial cells in both in vitro and in vivo models.
    Respir Res. 2023;24:205.
    

    >> Share

    
    
96. BURBANK AJ, Atkinson CE, Espaillat AE, Schworer SA, et al
    Race-specific spirometry equations may overestimate asthma control in Black children and adolescents.
    Respir Res. 2023;24:203.
    

    >> Share

    
    
97. TAKIMOTO-SATO M, Suzuki M, Kimura H, Ge H, et al
    Apoptosis inhibitor of macrophage (AIM)/CD5L is involved in the pathogenesis of COPD.
    Respir Res. 2023;24:201.
    

    >> Share

    
    
98. KRAMER EL, Hudock KM, Davidson CR, Clancy JP, et al
    CFTR dysfunction in smooth muscle drives TGFbeta dependent airway hyperreactivity.
    Respir Res. 2023;24:198.
    

    >> Share

    
    July 2023
99. CAZZOLA M, Page CP, Wedzicha JA, Celli BR, et al
    Use of thiols and implications for the use of inhaled corticosteroids in the presence of oxidative stress in COPD.
    Respir Res. 2023;24:194.
    

    >> Share

    
    
100. COURSE CW, Lewis PA, Kotecha SJ, Cousins M, et al
     Characterizing the urinary proteome of prematurity-associated lung disease in school-aged children.
     Respir Res. 2023;24:191.
     

     >> Share

     
     
101. BALDOMERO AK, MacDonald DM, Kaplan A, Lock E, et al
     Bilirubin-associated single nucleotide polymorphism (SNP) and respiratory health outcomes: a mendelian randomization study.
     Respir Res. 2023;24:190.
     

     >> Share

     
     
102. JONES AC, Leffler J, Laing IA, Bizzintino J, et al
     LPS binding protein and activation signatures are upregulated during asthma exacerbations in children.
     Respir Res. 2023;24:184.
     

     >> Share

     
     
103. STRULOVICI-BAREL Y, Kaner RJ, Crystal RG
     High apoptotic endothelial microparticle levels measured in asthma with elevated IgE and eosinophils.
     Respir Res. 2023;24:180.
     

     >> Share

     
     
104. RASPE J, Schmitz MS, Barbet K, Caso GC, et al
     Therapeutic properties of Helicobacter pylori-derived vacuolating cytotoxin A in an animal model of chronic allergic airway disease.
     Respir Res. 2023;24:178.
     

     >> Share

     
     June 2023
105. KAMSTRUP P, Sivapalan P, Ronn C, Rastoder E, et al
     Fibrin degradation products and survival in patients with chronic obstructive pulmonary disease: a protocolized prospective observational study.
     Respir Res. 2023;24:172.
     

     >> Share

     
     
106. HAKANSSON KEJ, Guerrero SC, Backer V, Ulrik CS, et al
     Burden and unmet need for specialist care in poorly controlled and severe childhood asthma in a Danish nationwide cohort.
     Respir Res. 2023;24:173.
     

     >> Share

     
     
107. WANG Z, Li Y, Gao Y, Fu Y, et al
     Global, regional, and national burden of asthma and its attributable risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019.
     Respir Res. 2023;24:169.
     

     >> Share

     
     
108. WANG Z, He Y, Li Q, Zhao Y, et al
     Dysregulation of iron homeostasis in airways associated with persistent preschool wheezing.
     Respir Res. 2023;24:170.
     

     >> Share

     
     
109. AHN SY, Lee J, Lee DH, Ho TL, et al
     Chronic allergic asthma induces T-cell exhaustion and impairs virus clearance in mice.
     Respir Res. 2023;24:160.
     

     >> Share

     
     
110. LIU P, Zhang M, Gao H, Han S, et al
     Regulation of whole-transcriptome sequencing expression in COPD after personalized precise exercise training: a pilot study.
     Respir Res. 2023;24:156.
     

     >> Share

     
     
111. DONOGHUE LJ, McFadden KM, Vargas D, Smith GJ, et al
     Collaborative cross strain CC011/UncJ as a novel mouse model of T2-high, severe asthma.
     Respir Res. 2023;24:153.
     

     >> Share

     
     
112. ROGNONI C, Milano C, Heffler E, Bonini M, et al
     Economic impact of a more extensive use of FENO testing on the Italian population with asthma.
     Respir Res. 2023;24:147.
     

     >> Share

     
     
113. TALKER L, Neville D, Wiffen L, Selim AB, et al
     Machine diagnosis of chronic obstructive pulmonary disease using a novel fast-response capnometer.
     Respir Res. 2023;24:150.
     

     >> Share

     
     May 2023
114. KANJ AN, Kottom TJ, Schaefbauer KJ, Choudhury M, et al
     Dysbiosis of the intestinal fungal microbiota increases lung resident group 2 innate lymphoid cells and is associated with enhanced asthma severity in mice and humans.
     Respir Res. 2023;24:144.
     

     >> Share

     
     
115. BATTAGLINI D, Parodi L, Cinotti R, Asehnoune K, et al
     Ventilator-associated pneumonia in neurocritically ill patients: insights from the ENIO international prospective observational study.
     Respir Res. 2023;24:146.
     

     >> Share

     
     
116. KNOX-BROWN B, Patel J, Potts J, Ahmed R, et al
     The association of spirometric small airways obstruction with respiratory symptoms, cardiometabolic diseases, and quality of life: results from the Burden of Obstructive Lung Disease (BOLD) study.
     Respir Res. 2023;24:137.
     

     >> Share

     
     
117. VULTAGGIO A, Aliani M, Altieri E, Bracciale P, et al
     Long-term effectiveness of benralizumab in severe eosinophilic asthma patients treated for 96-weeks: data from the ANANKE study.
     Respir Res. 2023;24:135.
     

     >> Share

     
     
118. CIPOLLA D, Zhang J, Korkmaz B, Chalmers JD, et al
     Dipeptidyl peptidase-1 inhibition with brensocatib reduces the activity of all major neutrophil serine proteases in patients with bronchiectasis: results from the WILLOW trial.
     Respir Res. 2023;24:133.
     

     >> Share

     
     
119. WANG R, Huang C, Yang W, Wang C, et al
     Respiratory microbiota and radiomics features in the stable COPD patients.
     Respir Res. 2023;24:131.
     

     >> Share

     
     
120. JUDE MS, Yang CX, Filho FSL, Hernandez Cordero AI, et al
     Microbial dysbiosis and the host airway epithelial response: insights into HIV-associated COPD using multi'omics profiling.
     Respir Res. 2023;24:124.
     

     >> Share

     
     
121. GENOFRE E, Carstens D, DeBacker W, Muchmore P, et al
     The effects of benralizumab on airway geometry and dynamics in severe eosinophilic asthma: a single-arm study design exploring a functional respiratory imaging approach.
     Respir Res. 2023;24:121.
     

     >> Share

     
     
122. CHEN W, Reddel HK, FitzGerald JM, Beasley R, et al
     Can we predict who will benefit most from biologics in severe asthma? A post-hoc analysis of two phase 3 trials.
     Respir Res. 2023;24:120.
     

     >> Share

     
     April 2023
123. TOMASZEWSKI EL, Atkinson MJ, Janson C, Karlsson N, et al
     Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD.
     Respir Res. 2023;24:106.
     

     >> Share

     
     
124. GUECAMBURU M, Coquelin A, Rapin A, Le Guen N, et al
     Pulmonary rehabilitation after severe exacerbation of COPD: a nationwide population study.
     Respir Res. 2023;24:102.
     

     >> Share

     
     
125. LI J, Zheng Z, Liu Y, Zhang H, et al
     IRAK-M has effects in regulation of lung epithelial inflammation.
     Respir Res. 2023;24:103.
     

     >> Share

     
     March 2023
126. LIN L, Song Q, Duan J, Liu C, et al
     The impact of impaired sleep quality on symptom change and future exacerbation of chronic obstructive pulmonary disease.
     Respir Res. 2023;24:98.
     

     >> Share

     
     
127. LUYSTER FS, Boudreaux-Kelly MY, Bon JM
     Insomnia in chronic obstructive pulmonary disease and associations with healthcare utilization and costs.
     Respir Res. 2023;24:93.
     

     >> Share

     
     
128. YANG Z, Li P, Yuan Q, Wang X, et al
     Inhibition of miR-4640-5p alleviates pulmonary hypertension in chronic obstructive pulmonary disease patients by regulating nitric oxide synthase 1.
     Respir Res. 2023;24:92.
     

     >> Share

     
     
129. ZILLI VIEIRA CL, Koutrakis P, Liu M, Gottlieb DJ, et al
     Intense solar activity reduces urinary 6-sulfatoxymelatonin in patients with COPD.
     Respir Res. 2023;24:91.
     

     >> Share

     
     
130. HE LX, Yang L, Liu T, Li YN, et al
     Group 3 innate lymphoid cells secret neutrophil chemoattractants and are insensitive to glucocorticoid via aberrant GR phosphorylation.
     Respir Res. 2023;24:90.
     

     >> Share

     
     
131. WANG LL, Lu HW, Li LL, Gao YH, et al
     Pseudomonas aeruginosa isolation is an important predictor for recurrent hemoptysis after bronchial artery embolization in patients with idiopathic bronchiectasis: a multicenter cohort study.
     Respir Res. 2023;24:84.
     

     >> Share

     
     
132. CHOI YJ, Han H, Lee JH, Lee J, et al
     Particulate matter(10)-induced airway inflammation and fibrosis can be regulated by chitinase-1 suppression.
     Respir Res. 2023;24:85.
     

     >> Share

     
     
133. TALAEI M, Emmett PM, Granell R, Tabatabaeian H, et al
     Dietary patterns, lung function and asthma in childhood: a longitudinal study.
     Respir Res. 2023;24:82.
     

     >> Share

     
     
134. HEIDARI-FOROOZAN M, Aryan A, Esfahani Z, Shahrbaf MA, et al
     National, subnational and risk attributed burden of chronic respiratory diseases in Iran from 1990 to 2019.
     Respir Res. 2023;24:74.
     

     >> Share

     
     
135. KANG J, Lee R, Lee SW
     Effects of gastroesophageal reflux disease treatment with proton pump inhibitors on the risk of acute exacerbation and pneumonia in patients with COPD.
     Respir Res. 2023;24:75.
     

     >> Share

     
     
136. ZHANG Z, Wang J, Li Y, Liu F, et al
     Proteomics and metabolomics profiling reveal panels of circulating diagnostic biomarkers and molecular subtypes in stable COPD.
     Respir Res. 2023;24:73.
     

     >> Share

     
     
137. HORTON DB, Neikirk AL, Yang Y, Huang C, et al
     Childhood asthma diagnoses declined during the COVID-19 pandemic in the United States.
     Respir Res. 2023;24:72.
     

     >> Share

     
     
138. FAVERIO P, Ronco R, Monzio Compagnoni M, Franchi M, et al
     Effectiveness and economic impact of Dupilumab in asthma: a population-based cohort study.
     Respir Res. 2023;24:70.
     

     >> Share

     
     
139. SONG Y, Fu W, Zhang Y, Huang D, et al
     Azithromycin ameliorated cigarette smoke-induced airway epithelial barrier dysfunction by activating Nrf2/GCL/GSH signaling pathway.
     Respir Res. 2023;24:69.
     

     >> Share

     
     February 2023
140. WANG XW, Wang T, Schaub DP, Chen C, et al
     Benchmarking omics-based prediction of asthma development in children.
     Respir Res. 2023;24:63.
     

     >> Share

     
     
141. LIN X, Wang L, Lu X, Zhang Y, et al
     Targeting of G-protein coupled receptor 40 alleviates airway hyperresponsiveness through RhoA/ROCK1 signaling pathway in obese asthmatic mice.
     Respir Res. 2023;24:56.
     

     >> Share

     
     
142. KWOK WC, Tam TCC, Lam DCL, Leung JKC, et al
     Worsening of asthma control after recovery from mild to moderate COVID-19 in patients from Hong Kong.
     Respir Res. 2023;24:53.
     

     >> Share

     
     
143. XU X, Zheng F, Xu S, Hu M, et al
     Decreased ubiquitin modifying enzyme A20 associated with hyper-responsiveness to ovalbumin challenge following intrauterine growth restriction.
     Respir Res. 2023;24:50.
     

     >> Share

     
     
144. KOKTURK N, Khodayari N, Lascano J, Riley EL, et al
     Lung Inflammation in alpha-1-antitrypsin deficient individuals with normal lung function.
     Respir Res. 2023;24:40.
     

     >> Share

     
     
145. HAYDEN LP, Hobbs BD, Busch R, Cho MH, et al
     X chromosome associations with chronic obstructive pulmonary disease and related phenotypes: an X chromosome-wide association study.
     Respir Res. 2023;24:38.
     

     >> Share

     
     January 2023
146. DUAN Y, Zhou S, Wang J
     BRD4 is involved in viral exacerbation of chronic obstructive pulmonary disease.
     Respir Res. 2023;24:37.
     

     >> Share

     
     
147. SAFONOVA E, Yawn BP, Welte T, Wang C, et al
     Risk factors for herpes zoster: should people with asthma or COPD be vaccinated?
     Respir Res. 2023;24:35.
     

     >> Share

     
     
148. MEISCHL T, Schmid-Scherzer K, Vafai-Tabrizi F, Wurzinger G, et al
     The impact of diagnostic delay on survival in alpha-1-antitrypsin deficiency: results from the Austrian Alpha-1 Lung Registry.
     Respir Res. 2023;24:34.
     

     >> Share

     
     
149. TU X, Gomez HM, Kim RY, Brown AC, et al
     Airway and parenchyma transcriptomics in a house dust mite model of experimental asthma.
     Respir Res. 2023;24:32.
     

     >> Share

     
     
150. MELO-DIAS S, Cabral M, Furtado A, Souto-Miranda S, et al
     Responsiveness to pulmonary rehabilitation in COPD is associated with changes in microbiota.
     Respir Res. 2023;24:29.
     

     >> Share

     
     
151. BUSCHUR KL, Riley C, Saferali A, Castaldi P, et al
     Distinct COPD subtypes in former smokers revealed by gene network perturbation analysis.
     Respir Res. 2023;24:30.
     

     >> Share

     
     
152. GARCIA-GARCIA ML, Sastre B, Arroyas M, Beato M, et al
     Nasal TSLP and periostin in infants with severe bronchiolitis and risk of asthma at 4 years of age.
     Respir Res. 2023;24:26.
     

     >> Share

     
     
153. KRUK D, Yeung ACY, Faiz A, Ten Hacken NHT, et al
     Gene expression profiles in mesenchymal stromal cells from bone marrow, adipose tissue and lung tissue of COPD patients and controls.
     Respir Res. 2023;24:22.
     

     >> Share

     
     
154. VERSTRAETE K, Das N, Gyselinck I, Topalovic M, et al
     Principal component analysis of flow-volume curves in COPDGene to link spirometry with phenotypes of COPD.
     Respir Res. 2023;24:20.
     

     >> Share

     
     
155. SPRINGVLOET L, Triemstra M, Knottnerus B, Rolink M, et al
     Validation of the CaReQoL asthma: a patient reported outcome measure for monitoring the perceived effects of pulmonary rehabilitation in adult patients with severe refractory asthma.
     Respir Res. 2023;24:14.
     

     >> Share

     
     
156. GOULD GS, Hurst JR, Trofor A, Alison JA, et al
     Recognising the importance of chronic lung disease: a consensus statement from the Global Alliance for Chronic Diseases (Lung Diseases group).
     Respir Res. 2023;24:15.
     

     >> Share

     
     
157. QURAISHI E, Jibuaku C, Lisik D, Wennergren G, et al
     Comparison of clinician diagnosis of COVID-19 with real time polymerase chain reaction in an adult-representative population in Sweden.
     Respir Res. 2023;24:10.
     

     >> Share

     
     
158. ZHOU Z, Liang S, Zhou Z, Liu J, et al
     TGF-beta1 promotes SCD1 expression via the PI3K-Akt-mTOR-SREBP1 signaling pathway in lung fibroblasts.
     Respir Res. 2023;24:8.
     

     >> Share

     
     
159. BANDEIRA E, Jang SC, Lasser C, Johansson K, et al
     Effects of mesenchymal stem cell-derived nanovesicles in experimental allergic airway inflammation.
     Respir Res. 2023;24:3.
     

     >> Share

     
     
160. WORTH H, Buhl R, Criee CP, Kardos P, et al
     In 'real world' patients with COPD, exacerbation history, and not blood eosinophils, is the most reliable predictor of future exacerbations.
     Respir Res. 2023;24:2.
     

     >> Share

     
     December 2022
161. CHENG WH, Kao SY, Chen CL, Yuliani FS, et al
     Amphiregulin induces CCN2 and fibronectin expression by TGF-beta through EGFR-dependent pathway in lung epithelial cells.
     Respir Res. 2022;23:381.
     

     >> Share

     
     
162. LIU D, Xu W, Tang Y, Cao J, et al
     Nebulization of risedronate alleviates airway obstruction and inflammation of chronic obstructive pulmonary diseases via suppressing prenylation-dependent RAS/ERK/NF-kappaB and RhoA/ROCK1/MLCP signaling.
     Respir Res. 2022;23:380.
     

     >> Share

     
     
163. CAY P, Singer CA, Ba MA
     Gene network analysis for identification of microRNA biomarkers for asthma.
     Respir Res. 2022;23:378.
     

     >> Share

     
     
164. WANG R, Li W, Dai H, Zhu M, et al
     Correction to: PKD1 deficiency induces Bronchiectasis in a porcine ADPKD model.
     Respir Res. 2022;23:373.
     

     >> Share

     
     
165. AMEGADZIE JE, Gamble JM, Farrell J, Gao Z, et al
     Risk of all-cause mortality or hospitalization for pneumonia associated with inhaled beta2-agonists in patients with asthma, COPD or asthma-COPD overlap.
     Respir Res. 2022;23:364.
     

     >> Share

     
     
166. NOMURA N, Matsumoto H, Yokoyama A, Nishimura Y, et al
     Nationwide survey of refractory asthma with bronchiectasis by inflammatory subtypes.
     Respir Res. 2022;23:365.
     

     >> Share

     
     
167. HUANG Q, Wang Y, Zhang L, Qian W, et al
     Single-cell transcriptomics highlights immunological dysregulations of monocytes in the pathobiology of COPD.
     Respir Res. 2022;23:367.
     

     >> Share

     
     
168. TERRANOVA L, Rise P, Gramegna A, Pinna C, et al
     Pro-resolving and pro-inflammatory fatty acid-derived mediators in sputum of stable state bronchiectasis patients.
     Respir Res. 2022;23:363.
     

     >> Share

     
     
169. POURESLAMI I, FitzGerald JM, Tregobov N, Goldstein RS, et al
     Health literacy in asthma and chronic obstructive pulmonary disease (COPD) care: a narrative review and future directions.
     Respir Res. 2022;23:361.
     

     >> Share

     
     
170. DAI Z, Liu X, Zeng H, Chen Y, et al
     Long noncoding RNA HOTAIR facilitates pulmonary vascular endothelial cell apoptosis via DNMT1 mediated hypermethylation of Bcl-2 promoter in COPD.
     Respir Res. 2022;23:356.
     

     >> Share

     
     
171. GRIBBEN KC, Wyss AB, Poole JA, Farazi PA, et al
     Correction to: CC16 polymorphisms in asthma, asthma subtypes, and asthma control in adults from the Agricultural Lung Health Study.
     Respir Res. 2022;23:350.
     

     >> Share

     
     
172. MIRAVITLLES M, Turner AM, Torres-Duran M, Tanash H, et al
     Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry.
     Respir Res. 2022;23:352.
     

     >> Share

     
     
173. GOEL K, Egersdorf N, Gill A, Cao D, et al
     Characterization of pulmonary vascular remodeling and MicroRNA-126-targets in COPD-pulmonary hypertension.
     Respir Res. 2022;23:349.
     

     >> Share

     
     
174. MIRAVITLLES M, Garcia-Rivero JL, Ribera X, Galera J, et al
     Exercise capacity and physical activity in COPD patients treated with a LAMA/LABA combination: a systematic review and meta-analysis.
     Respir Res. 2022;23:347.
     

     >> Share

     
     
175. DUPONT A, Couffignal C, Arias C, Salah K, et al
     Outcomes and risk factors with COVID-19 or influenza in hospitalized asthma patients.
     Respir Res. 2022;23:342.
     

     >> Share

     
     
176. STUBBS MA, Clark VL, Gibson PG, Yorke J, et al
     Associations of symptoms of anxiety and depression with health-status, asthma control, dyspnoea, dysfunction breathing and obesity in people with severe asthma.
     Respir Res. 2022;23:341.
     

     >> Share

     
     
177. ELLER MCN, Pierantozzi Vergani K, Saraiva-Romanholo BM, de Souza Xavier Costa N, et al
     Bronchial eosinophils, neutrophils, and CD8 + T cells influence asthma control and lung function in schoolchildren and adolescents with severe treatment-resistant asthma.
     Respir Res. 2022;23:335.
     

     >> Share

     
     
178. VAN ZELST CM, Goossens LMA, Witte JA, Braunstahl GJ, et al
     Stratification of COPD patients towards personalized medicine: reproduction and formation of clusters.
     Respir Res. 2022;23:336.
     

     >> Share

     
     
179. TERPSTRA LC, Altenburg J, Bronsveld I, de Kruif MD, et al
     Effects of long-term tobramycin inhalation solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis.
     Respir Res. 2022;23:330.
     

     >> Share

     
     
180. GAO YH, Lu HW, Mao B, Guan WJ, et al
     The Establishment of China Bronchiectasis Registry and Research Collaboration (BE-China): Protocol of a prospective multicenter observational study.
     Respir Res. 2022;23:328.
     

     >> Share

     
     November 2022
181. LI W, Wang B, Tan M, Song X, et al
     Analysis of sputum microbial metagenome in COPD based on exacerbation frequency and lung function: a case control study.
     Respir Res. 2022;23:321.
     

     >> Share

     
     
182. FEIZI H, Alizadeh M, Nejadghaderi SA, Noori M, et al
     The burden of chronic obstructive pulmonary disease and its attributable risk factors in the Middle East and North Africa region, 1990-2019.
     Respir Res. 2022;23:319.
     

     >> Share

     
     
183. MA L, Zhu M, Li G, Gai J, et al
     Preclinical development of a long-acting trivalent bispecific nanobody targeting IL-5 for the treatment of eosinophilic asthma.
     Respir Res. 2022;23:316.
     

     >> Share

     
     
184. WANG WW, Mao B, Liu Y, Gu SY, et al
     Altered fecal microbiome and metabolome in adult patients with non-cystic fibrosis bronchiectasis.
     Respir Res. 2022;23:317.
     

     >> Share

     
     
185. WILSON AC, Bon JM, Mason S, Diaz AA, et al
     Increased chest CT derived bone and muscle measures capture markers of improved morbidity and mortality in COPD.
     Respir Res. 2022;23:311.
     

     >> Share

     
     
186. TEJWANI V, Woo H, Liu C, Tillery AK, et al
     Black carbon content in airway macrophages is associated with increased severe exacerbations and worse COPD morbidity in SPIROMICS.
     Respir Res. 2022;23:310.
     

     >> Share

     
     
187. LU J, Ge H, Qi L, Zhang S, et al
     Subtyping preserved ratio impaired spirometry (PRISm) by using quantitative HRCT imaging characteristics.
     Respir Res. 2022;23:309.
     

     >> Share

     
     
188. GRIBBEN KC, Wyss AB, Poole JA, Farazi PA, et al
     CC16 polymorphisms in asthma, asthma subtypes, and asthma control in adults from the Agricultural Lung Health Study.
     Respir Res. 2022;23:305.
     

     >> Share

     
     October 2022
189. ZHAO N, Wu F, Peng J, Zheng Y, et al
     Preserved ratio impaired spirometry is associated with small airway dysfunction and reduced total lung capacity.
     Respir Res. 2022;23:298.
     

     >> Share

     
     
190. WANG R, Li W, Dai H, Zhu M, et al
     PKD1 deficiency induces Bronchiectasis in a porcine ADPKD model.
     Respir Res. 2022;23:292.
     

     >> Share

     
     
191. XIA M, Xu F, Ni H, Wang Q, et al
     Neutrophil activation and NETosis are the predominant drivers of airway inflammation in an OVA/CFA/LPS induced murine model.
     Respir Res. 2022;23:289.
     

     >> Share

     
     
192. CHOI H, Kim SH, Han K, Park TS, et al
     Association between exercise and risk of cardiovascular diseases in patients with non-cystic fibrosis bronchiectasis.
     Respir Res. 2022;23:288.
     

     >> Share

     
     
193. RAO X, Dong H, Zhang W, Sun H, et al
     MiR-493-5p inhibits Th9 cell differentiation in allergic asthma by targeting FOXO1.
     Respir Res. 2022;23:286.
     

     >> Share

     
     
194. JACOBS M, Verschraegen S, Salhi B, Anckaert J, et al
     IL-10 producing regulatory B cells are decreased in blood from smokers and COPD patients.
     Respir Res. 2022;23:287.
     

     >> Share

     
     
195. CASADEVALL C, Sancho-Munoz A, Vicente I, Pascual-Guardia S, et al
     Influence of COPD systemic environment on the myogenic function of muscle precursor cells in vitro.
     Respir Res. 2022;23:282.
     

     >> Share

     
     
196. ANDREAS A, Maloy A, Nyunoya T, Zhang Y, et al
     The FoxP1 gene regulates lung function, production of matrix metalloproteinases and inflammatory mediators, and viability of lung epithelia.
     Respir Res. 2022;23:281.
     

     >> Share

     
     
197. HUSSAIN SS, Edwards YJK, Libby EF, Stanford D, et al
     Comparative transcriptomics in human COPD reveals dysregulated genes uniquely expressed in ferrets.
     Respir Res. 2022;23:277.
     

     >> Share

     
     
198. YI F, Zhan C, Liu B, Li H, et al
     Effects of treatment with montelukast alone, budesonide/formoterol alone and a combination of both in cough variant asthma.
     Respir Res. 2022;23:279.
     

     >> Share

     
     
199. JIANG T, Hu W, Zhang S, Ren C, et al
     Fibroblast growth factor 10 attenuates chronic obstructive pulmonary disease by protecting against glycocalyx impairment and endothelial apoptosis.
     Respir Res. 2022;23:269.
     

     >> Share

     
     
200. PAULIN LM, Halenar MJ, Edwards KC, Lauten K, et al
     Association of tobacco product use with chronic obstructive pulmonary disease (COPD) prevalence and incidence in Waves 1 through 5 (2013-2019) of the Population Assessment of Tobacco and Health (PATH) Study.
     Respir Res. 2022;23:273.
     

     >> Share

     
     September 2022
201. FALLAHZADEH A, Sharifnejad Tehrani Y, Sheikhy A, Ghamari SH, et al
     The burden of chronic respiratory disease and attributable risk factors in North Africa and Middle East: findings from global burden of disease study (GBD) 2019.
     Respir Res. 2022;23:268.
     

     >> Share

     
     
202. DIVO MJ, Marin JM, Casanova C, Cabrera Lopez C, et al
     Comorbidities and mortality risk in adults younger than 50 years of age with chronic obstructive pulmonary disease.
     Respir Res. 2022;23:267.
     

     >> Share

     
     
203. XU J, Sun X, Zhu H, Cao Y, et al
     Long-term variability of impulse oscillometry and spirometry in stable COPD and asthma.
     Respir Res. 2022;23:262.
     

     >> Share

     
     
204. DALEY-YATES P, Keppler B, Baines A, Bardsley G, et al
     Metabolomic changes related to airway inflammation, asthma pathogenesis and systemic activity following inhaled fluticasone furoate/vilanterol: a randomized controlled trial.
     Respir Res. 2022;23:258.
     

     >> Share

     
     
205. PEI Y, Wei Y, Peng B, Wang M, et al
     Combining single-cell RNA sequencing of peripheral blood mononuclear cells and exosomal transcriptome to reveal the cellular and genetic profiles in COPD.
     Respir Res. 2022;23:260.
     

     >> Share

     
     
206. MAGWENZI P, Rusakaniko S, Sibanda EN, Gumbo FZ, et al
     Challenges in the diagnosis of asthma in children, what are the solutions? A scoping review of 3 countries in sub Saharan Africa.
     Respir Res. 2022;23:254.
     

     >> Share

     
     
207. YAMADA H, Matsumoto I, Makita N, Arita Y, et al
     Effect of timing of bronchodilator therapy initiation on exacerbations in patients with chronic obstructive pulmonary disease: a retrospective cohort study.
     Respir Res. 2022;23:255.
     

     >> Share

     
     
208. LIU Y, Shi G
     Roles of sirtuins in asthma.
     Respir Res. 2022;23:251.
     

     >> Share

     
     
209. HUANG D, He D, Gong L, Yao R, et al
     A prediction model for hospital mortality in patients with severe community-acquired pneumonia and chronic obstructive pulmonary disease.
     Respir Res. 2022;23:250.
     

     >> Share

     
     
210. GRIBBEN KC, Poole JA, Nelson AJ, Farazi PA, et al
     Relationships of serum CC16 levels with smoking status and lung function in COPD.
     Respir Res. 2022;23:247.
     

     >> Share

     
     
211. LEUNG C, Ryu MH, Bolling AK, Maestre-Batlle D, et al
     Peroxisome proliferator-activated receptor gamma gene variants modify human airway and systemic responses to indoor dibutyl phthalate exposure.
     Respir Res. 2022;23:248.
     

     >> Share

     
     
212. FENG KN, Meng P, Zou XL, Zhang M, et al
     IL-37 protects against airway remodeling by reversing bronchial epithelial-mesenchymal transition via IL-24 signaling pathway in chronic asthma.
     Respir Res. 2022;23:244.
     

     >> Share

     
     
213. ZHOU J, Yi F, Wu F, Xu P, et al
     Characteristics of different asthma phenotypes associated with cough: a prospective, multicenter survey in China.
     Respir Res. 2022;23:243.
     

     >> Share

     
     
214. LENG S, Picchi MA, Meek PM, Jiang M, et al
     Wood smoke exposure affects lung aging, quality of life, and all-cause mortality in New Mexican smokers.
     Respir Res. 2022;23:236.
     

     >> Share

     
     
215. LEE HW, Baek MG, Choi S, Ahn YH, et al
     Peripheral blood transcriptomic clusters uncovered immune phenotypes of asthma.
     Respir Res. 2022;23:237.
     

     >> Share

     
     
216. KHODAYARI N, Oshins R, Mehrad B, Lascano JE, et al
     Cigarette smoke exposed airway epithelial cell-derived EVs promote pro-inflammatory macrophage activation in alpha-1 antitrypsin deficiency.
     Respir Res. 2022;23:232.
     

     >> Share

     
     
217. LEE CH, Kim MS, Yeo SH, Rhee CK, et al
     Treatment patterns and cost of exacerbations in patients with chronic obstructive pulmonary disease using multiple inhaler triple therapy in South Korea.
     Respir Res. 2022;23:231.
     

     >> Share

     
     
218. ALTHOFF MD, Jimenez G, Peterson R, Jin Y, et al
     Differences in L-arginine metabolism and asthma morbidity among asthma patients with and without obstructive sleep apnea.
     Respir Res. 2022;23:230.
     

     >> Share

     
     
219. DAI C, Wu F, Wang Z, Peng J, et al
     The association between small airway dysfunction and aging: a cross-sectional analysis from the ECOPD cohort.
     Respir Res. 2022;23:229.
     

     >> Share

     
     August 2022
220. SU X, Wu W, Zhu Z, Lin X, et al
     The effects of epithelial-mesenchymal transitions in COPD induced by cigarette smoke: an update.
     Respir Res. 2022;23:225.
     

     >> Share

     
     
221. SHIN S, Kong S, Kang D, Lee G, et al
     Longitudinal changes in pulmonary function and patient-reported outcomes after lung cancer surgery.
     Respir Res. 2022;23:224.
     

     >> Share

     
     
222. ROGLIANI P, Cavalli F, Ritondo BL, Cazzola M, et al
     Sex differences in adult asthma and COPD therapy: a systematic review.
     Respir Res. 2022;23:222.
     

     >> Share

     
     
223. KOMURA M, Sato T, Yoshikawa H, Nitta NA, et al
     Propylene glycol, a component of electronic cigarette liquid, damages epithelial cells in human small airways.
     Respir Res. 2022;23:216.
     

     >> Share

     
     
224. HURST JR, Han MK, Singh B, Sharma S, et al
     Prognostic risk factors for moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease: a systematic literature review.
     Respir Res. 2022;23:213.
     

     >> Share

     
     
225. JO YS, Kim KJ, Rhee CK, Yoo KH, et al
     Prevalence, characteristics, and risk of exacerbation in young patients with chronic obstructive pulmonary disease.
     Respir Res. 2022;23:212.
     

     >> Share

     
     
226. SMALLWOOD N, Pascoe A, Vogrin S, Philip J, et al
     SINFONIA study protocol: a phase II/III randomised controlled trial examining benefits of guided online group singing in people with chronic obstructive pulmonary disease and interstitial lung disease and their carers.
     Respir Res. 2022;23:208.
     

     >> Share

     
     
227. DE LUCA G, Nardin M, Algowhary M, Uguz B, et al
     Impact of chronic obstructive pulmonary disease on short-term outcome in patients with ST-elevation myocardial infarction during COVID-19 pandemic: insights from the international multicenter ISACS-STEMI registry.
     Respir Res. 2022;23:207.
     

     >> Share

     
     
228. DI STEFANO A, Dossena F, Gnemmi I, D'Anna SE, et al
     Decreased humoral immune response in the bronchi of rapid decliners with chronic obstructive pulmonary disease.
     Respir Res. 2022;23:200.
     

     >> Share

     
     July 2022
229. BODUM KS, Hjerrild BE, Dalsgaard S, Rubak SLM, et al
     Behavioural side effects of inhaled corticosteroids among children and adolescents with asthma.
     Respir Res. 2022;23:192.
     

     >> Share

     
     
230. KAN M, Sun M, Jiang X, Diwadkar AR, et al
     CEBPD modulates the airway smooth muscle transcriptomic response to glucocorticoids.
     Respir Res. 2022;23:193.
     

     >> Share

     
     
231. RIEG AD, Suleiman S, Anker C, Bunting NA, et al
     Platelet-derived growth factor (PDGF)-BB regulates the airway tone via activation of MAP2K, thromboxane, actin polymerisation and Ca(2+)-sensitisation.
     Respir Res. 2022;23:189.
     

     >> Share

     
     
232. CHEN CH, Wu CD, Lee YL, Lee KY, et al
     Air pollution enhance the progression of restrictive lung function impairment and diffusion capacity reduction: an elderly cohort study.
     Respir Res. 2022;23:186.
     

     >> Share

     
     
233. BIGNOLD R, Shammout B, Rowley JE, Repici M, et al
     Chemokine CXCL12 drives pericyte accumulation and airway remodeling in allergic airway disease.
     Respir Res. 2022;23:183.
     

     >> Share

     
     
234. LEEM AY, Kim YS, Chung KS, Park MS, et al
     Sarcopenia is associated with cardiovascular risk in men with COPD, independent of adiposity.
     Respir Res. 2022;23:185.
     

     >> Share

     
     
235. HOU J, Wang X, Su C, Ma W, et al
     Reduced frequencies of Foxp3(+)GARP(+) regulatory T cells in COPD patients are associated with multi-organ loss of tissue phenotype.
     Respir Res. 2022;23:176.
     

     >> Share

     
     June 2022
236. GOUDARZI H, Kimura H, Kimura H, Makita H, et al
     Effects of obesity on CC16 and their potential role in overweight/obese asthma.
     Respir Res. 2022;23:174.
     

     >> Share

     
     
237. SURAYA R, Nagano T, Ryanto GRT, Effendi WI, et al
     Budesonide/glycopyrronium/formoterol fumarate triple therapy prevents pulmonary hypertension in a COPD mouse model via NFkappaB inactivation.
     Respir Res. 2022;23:173.
     

     >> Share

     
     
238. HONG Y, Deng M, Hu W, Zhang R, et al
     Weak cough is associated with increased mortality in COPD patients with scheduled extubation: a two-year follow-up study.
     Respir Res. 2022;23:166.
     

     >> Share

     
     
239. LE NPK, do Nascimento AF, Schneberger D, Quach CC, et al
     Deficiency of leukocyte-specific protein 1 (LSP1) alleviates asthmatic inflammation in a mouse model.
     Respir Res. 2022;23:165.
     

     >> Share

     
     
240. MARIN-OTO M, Sanz-Rubio D, Santamaria-Martos F, Benitez I, et al
     Soluble RAGE in COPD, with or without coexisting obstructive sleep apnoea.
     Respir Res. 2022;23:163.
     

     >> Share

     
     
241. QIN W, Huang H, Dai Y, Han W, et al
     Proteome analysis of urinary biomarkers in a cigarette smoke-induced COPD rat model.
     Respir Res. 2022;23:156.
     

     >> Share

     
     
242. LIU P, Wang Y, Zhang N, Zhao X, et al
     Comprehensive identification of RNA transcripts and construction of RNA network in chronic obstructive pulmonary disease.
     Respir Res. 2022;23:154.
     

     >> Share

     
     
243. LOPEZ-CAMPOS JL, Osaba L, Czischke K, Jardim JR, et al
     Feasibility of a genotyping system for the diagnosis of alpha1 antitrypsin deficiency: a multinational cross-sectional analysis.
     Respir Res. 2022;23:152.
     

     >> Share

     
     
244. SALO PM, Mendy A, Wilkerson J, Molsberry SA, et al
     Serum antioxidant vitamins and respiratory morbidity and mortality: a pooled analysis.
     Respir Res. 2022;23:150.
     

     >> Share

     
     
245. SCHNEIDER S, Merfort I, Idzko M, Zech A, et al
     Blocking P2X purinoceptor 4 signalling alleviates cigarette smoke induced pulmonary inflammation.
     Respir Res. 2022;23:148.
     

     >> Share

     
     
246. KIM SY, Lee HJ, Lee JK, Park TY, et al
     Association between oxygen saturation level during bronchoscopy and post-bronchoscopy adverse events: a retrospective cohort study.
     Respir Res. 2022;23:144.
     

     >> Share

     
     May 2022
247. LEE H, Kovacs C, Mattman A, Hollander Z, et al
     The impact of IgG subclass deficiency on the risk of mortality in hospitalized patients with COPD.
     Respir Res. 2022;23:141.
     

     >> Share

     
     
248. XIONG XF, Zhu M, Wu HX, Fan LL, et al
     Immunophenotype in acute exacerbation of chronic obstructive pulmonary disease: a cross-sectional study.
     Respir Res. 2022;23:137.
     

     >> Share

     
     
249. ALQARNI AA, Brand OJ, Pasini A, Alahmari M, et al
     Imbalanced prostanoid release mediates cigarette smoke-induced human pulmonary artery cell proliferation.
     Respir Res. 2022;23:136.
     

     >> Share

     
     
250. IHRIE MD, McQuade VL, Womble JT, Hegde A, et al
     Exogenous leptin enhances markers of airway fibrosis in a mouse model of chronic allergic airways disease.
     Respir Res. 2022;23:131.
     

     >> Share

     
     
251. PINCIKOVA T, Parrot T, Hjelte L, Hogman M, et al
     MAIT cell counts are associated with the risk of hospitalization in COPD.
     Respir Res. 2022;23:127.
     

     >> Share

     
     
252. JACKSON D, Walum J, Banerjee P, Lewis BW, et al
     Th1 cytokines synergize to change gene expression and promote corticosteroid insensitivity in pediatric airway smooth muscle.
     Respir Res. 2022;23:126.
     

     >> Share

     
     
253. ZHAN Y, Chen J, Wu J, Gu Y, et al
     Human epididymis protein 4 aggravates airway inflammation and remodeling in chronic obstructive pulmonary disease.
     Respir Res. 2022;23:120.
     

     >> Share

     
     
254. HUANG K, Li F, Wang X, Yan B, et al
     Clinical and cytokine patterns of uncontrolled asthma with and without comorbid chronic rhinosinusitis: a cross-sectional study.
     Respir Res. 2022;23:119.
     

     >> Share

     
     
255. LIU Y, Qu HQ, Qu J, Chang X, et al
     Burden of rare coding variants reveals genetic heterogeneity between obese and non-obese asthma patients in the African American population.
     Respir Res. 2022;23:116.
     

     >> Share

     
     
256. FENG J, Sun L, Sun X, Xu L, et al
     Increasing prevalence and burden of bronchiectasis in urban Chinese adults, 2013-2017: a nationwide population-based cohort study.
     Respir Res. 2022;23:111.
     

     >> Share

     
     
257. GALGANI I, Annaratone M, Casula D, Di Maro G, et al
     Safety and immunogenicity of three doses of non-typeable Haemophilus influenzae-Moraxella catarrhalis (NTHi-Mcat) vaccine when administered according to two different schedules: a phase 2, randomised, observer-blind study.
     Respir Res. 2022;23:114.
     

     >> Share

     
     
258. KIM HS, An CH, Teller D, Moon SJ, et al
     The role of retinoid-related orphan receptor-alpha in cigarette smoke-induced autophagic response.
     Respir Res. 2022;23:110.
     

     >> Share

     
     
259. MAGNUSSON JM, Ericson P, Tengvall S, Stockfelt M, et al
     Involvement of IL-26 in bronchiolitis obliterans syndrome but not in acute rejection after lung transplantation.
     Respir Res. 2022;23:108.
     

     >> Share

     
     
260. VOGELMEIER CF, Worth H, Buhl R, Criee CP, et al
     Impact of switching from triple therapy to dual bronchodilation in COPD: the DACCORD 'real world' study.
     Respir Res. 2022;23:109.
     

     >> Share

     
     April 2022
261. YANG T, Cai B, Cao B, Kang J, et al
     Severity distribution and treatment of chronic obstructive pulmonary disease in China: baseline results of an observational study.
     Respir Res. 2022;23:106.
     

     >> Share

     
     
262. HAWTHORNE G, Richardson M, Greening NJ, Esliger D, et al
     A proof of concept for continuous, non-invasive, free-living vital signs monitoring to predict readmission following an acute exacerbation of COPD: a prospective cohort study.
     Respir Res. 2022;23:102.
     

     >> Share

     
     
263. GHOSH AJ, Hobbs BD, Yun JH, Saferali A, et al
     Lung tissue shows divergent gene expression between chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.
     Respir Res. 2022;23:97.
     

     >> Share

     
     
264. GUIOT J, Henket M, Frix AN, Gester F, et al
     Combined obstructive airflow limitation associated with interstitial lung diseases (O-ILD): the bad phenotype ?
     Respir Res. 2022;23:89.
     

     >> Share

     
     
265. ZOU J, Sun T, Song X, Liu YM, et al
     Distributions and trends of the global burden of COPD attributable to risk factors by SDI, age, and sex from 1990 to 2019: a systematic analysis of GBD 2019 data.
     Respir Res. 2022;23:90.
     

     >> Share

     
     
266. LI R, Chen Y, Zhao A, Huang L, et al
     Exploring genetic association of insomnia with allergic disease and asthma: a bidirectional Mendelian randomization study.
     Respir Res. 2022;23:84.
     

     >> Share

     
     
267. GOMEZ N, James V, Onion D, Fairclough LC, et al
     Extracellular vesicles and chronic obstructive pulmonary disease (COPD): a systematic review.
     Respir Res. 2022;23:82.
     

     >> Share

     
     
268. KELLY TL, Ward M, Pratt NL, Ramsay E, et al
     The association between exacerbation of chronic obstructive pulmonary disease and timing of paracetamol use: a cohort study in elderly Australians.
     Respir Res. 2022;23:80.
     

     >> Share

     
     March 2022
269. LEE KY, Wu SM, Kou HY, Chen KY, et al
     Association of air pollution exposure with exercise-induced oxygen desaturation in COPD.
     Respir Res. 2022;23:77.
     

     >> Share

     
     
270. YU C, Huang W, Zhou Z, Liang S, et al
     Short isoform thymic stromal lymphopoietin reduces inflammation and aerobic glycolysis of asthmatic airway epithelium by antagonizing long isoform thymic stromal lymphopoietin.
     Respir Res. 2022;23:75.
     

     >> Share

     
     
271. LU W, Tian Q, Xu R, Zhong C, et al
     Short-term exposure to ambient air pollution and pneumonia hospital admission among patients with COPD: a time-stratified case-crossover study.
     Respir Res. 2022;23:71.
     

     >> Share

     
     
272. YU H, Lin Y, Zhong Y, Guo X, et al
     Impaired AT2 to AT1 cell transition in PM2.5-induced mouse model of chronic obstructive pulmonary disease.
     Respir Res. 2022;23:70.
     

     >> Share

     
     
273. ROHL A, Baek SH, Kachroo P, Morrow JD, et al
     Protein interaction networks provide insight into fetal origins of chronic obstructive pulmonary disease.
     Respir Res. 2022;23:69.
     

     >> Share

     
     
274. ZHANG XY, Li W, Zhang JR, Li CY, et al
     Roles of sirtuin family members in chronic obstructive pulmonary disease.
     Respir Res. 2022;23:66.
     

     >> Share

     
     
275. HOFFMANN C, Maglakelidze M, von Schneidemesser E, Witt C, et al
     Asthma and COPD exacerbation in relation to outdoor air pollution in the metropolitan area of Berlin, Germany.
     Respir Res. 2022;23:64.
     

     >> Share

     
     
276. HSU CW, Suk CW, Hsu YP, Chang JH, et al
     Sphingosine-1-phosphate and CRP as potential combination biomarkers in discrimination of COPD with community-acquired pneumonia and acute exacerbation of COPD.
     Respir Res. 2022;23:63.
     

     >> Share

     
     
277. BRENNAN M, McDonnell MJ, Harrison MJ, Duignan N, et al
     Antimicrobial therapies for prevention of recurrent acute exacerbations of COPD (AECOPD): beyond the guidelines.
     Respir Res. 2022;23:58.
     

     >> Share

     
     
278. SHIN SH, Kwon SO, Kim V, Silverman EK, et al
     Association of body mass index and COPD exacerbation among patients with chronic bronchitis.
     Respir Res. 2022;23:52.
     

     >> Share

     
     
279. HUANG JJ, Yang XQ, Zhuo ZQ, Yuan L, et al
     Clinical characteristics of plastic bronchitis in children: a retrospective analysis of 43 cases.
     Respir Res. 2022;23:51.
     

     >> Share

     
     
280. WEITOFT M, Kadefors M, Stenberg H, Tufvesson E, et al
     Plasma proteome changes linked to late phase response after inhaled allergen challenge in asthmatics.
     Respir Res. 2022;23:50.
     

     >> Share

     
     
281. MIRAVITLLES M, Soler-Cataluna JJ, Soriano JB, Garcia-Rio F, et al
     Determinants of blood eosinophil levels in the general population and patients with COPD: a population-based, epidemiological study.
     Respir Res. 2022;23:49.
     

     >> Share

     
     
282. KORN S, Howarth P, Smith SG, Price RG, et al
     Development of methodology for assessing steroid-tapering in clinical trials for biologics in asthma.
     Respir Res. 2022;23:45.
     

     >> Share

     
     
283. BLASKOVIC S, Donati Y, Ruchonnet-Metrailler I, Avila Y, et al
     Early life exposure to nicotine modifies lung gene response after elastase-induced emphysema.
     Respir Res. 2022;23:44.
     

     >> Share

     
     
284. DE VRIES M, Nwozor KO, Muizer K, Wisman M, et al
     The relation between age and airway epithelial barrier function.
     Respir Res. 2022;23:43.
     

     >> Share

     
     
285. IRIE H, Ozaki M, Chubachi S, Hegab AE, et al
     Short-term intermittent cigarette smoke exposure enhances alveolar type 2 cell stemness via fatty acid oxidation.
     Respir Res. 2022;23:41.
     

     >> Share

     
     February 2022
286. CHEN Y, Kong D, Fu J, Zhang Y, et al
     Associations between ambient temperature and adult asthma hospitalizations in Beijing, China: a time-stratified case-crossover study.
     Respir Res. 2022;23:38.
     

     >> Share

     
     
287. MENZELLA F, Bargagli E, Aliani M, Bracciale P, et al
     ChAracterization of ItaliaN severe uncontrolled Asthmatic patieNts Key features when receiving Benralizumab in a real-life setting: the observational rEtrospective ANANKE study.
     Respir Res. 2022;23:36.
     

     >> Share

     
     
288. KULBACKA-ORTIZ K, Triest FJJ, Franssen FME, Wouters EFM, et al
     Restricted spirometry and cardiometabolic comorbidities: results from the international population based BOLD study.
     Respir Res. 2022;23:34.
     

     >> Share

     
     
289. SCHAUNAMAN N, Dimasuay KG, Kraft M, Chu HW, et al
     Tollip interaction with STAT3: a novel mechanism to regulate human airway epithelial responses to type 2 cytokines.
     Respir Res. 2022;23:31.
     

     >> Share

     
     
290. MARQUES A, Souto-Miranda S, Machado A, Oliveira A, et al
     COPD profiles and treatable traits using minimal resources: identification, decision tree and stability over time.
     Respir Res. 2022;23:30.
     

     >> Share

     
     
291. PARK SW, Lim MN, Kim WJ, Bak SH, et al
     Quantitative assessment the longitudinal changes of pulmonary vascular counts in chronic obstructive pulmonary disease.
     Respir Res. 2022;23:29.
     

     >> Share

     
     
292. CUI Y, Zhan Z, Ma Y, Huang K, et al
     Clinical and economic burden of comorbid coronary artery disease in patients with acute exacerbation of chronic obstructive pulmonary disease: sex differences in a nationwide cohort study.
     Respir Res. 2022;23:28.
     

     >> Share

     
     
293. WANG H, Zhong Y, Li N, Yu M, et al
     Transcriptomic analysis and validation reveal the pathogenesis and a novel biomarker of acute exacerbation of chronic obstructive pulmonary disease.
     Respir Res. 2022;23:27.
     

     >> Share

     
     
294. SINGH D, Wild JM, Saralaya D, Lawson R, et al
     Effect of indacaterol/glycopyrronium on ventilation and perfusion in COPD: a randomized trial.
     Respir Res. 2022;23:26.
     

     >> Share

     
     January 2022
295. WU W, Gao J, Chen D, Chen G, et al
     Epithelial microRNA-30a-3p targets RUNX2/HMGB1 axis to suppress airway eosinophilic inflammation in asthma.
     Respir Res. 2022;23:17.
     

     >> Share

     
     
296. MELO-DIAS S, Valente C, Andrade L, Marques A, et al
     Saliva as a non-invasive specimen for COPD assessment.
     Respir Res. 2022;23:16.
     

     >> Share

     
     
297. KOO HK, Hoth KF, Make BJ, Regan EA, et al
     Optimism is associated with respiratory symptoms and functional status in chronic obstructive pulmonary disease.
     Respir Res. 2022;23:19.
     

     >> Share

     
     
298. KLONT F, Horvatovich P, Bowler RP, van Rikxoort E, et al
     Plasma sRAGE levels strongly associate with centrilobular emphysema assessed by HRCT scans.
     Respir Res. 2022;23:15.
     

     >> Share

     
     
299. LUTHGEN M, Ruller S, Herzmann C
     Characteristics of the deventilation syndrome in COPD patients treated with non-invasive ventilation: an explorative study.
     Respir Res. 2022;23:13.
     

     >> Share

     
     
300. HUANG X, Guan W, Xiang B, Wang W, et al
     MUC5B regulates goblet cell differentiation and reduces inflammation in a murine COPD model.
     Respir Res. 2022;23:11.
     

     >> Share

     
     
301. CHIU YC, Lee SW, Liu CW, Lan TY, et al
     Relationship between gut microbiota and lung function decline in patients with chronic obstructive pulmonary disease: a 1-year follow-up study.
     Respir Res. 2022;23:10.
     

     >> Share

     
     
302. HO T, Nichols M, Nair G, Radford K, et al
     Iron in airway macrophages and infective exacerbations of chronic obstructive pulmonary disease.
     Respir Res. 2022;23:8.
     

     >> Share

     
     
303. ZHU Z, Lian X, Su X, Wu W, et al
     Exosomes derived from adipose-derived stem cells alleviate cigarette smoke-induced lung inflammation and injury by inhibiting alveolar macrophages pyroptosis.
     Respir Res. 2022;23:5.
     

     >> Share

     
     
304. LOMMATZSCH M, Speer T, Herr C, Jorres RA, et al
     IgE is associated with exacerbations and lung function decline in COPD.
     Respir Res. 2022;23:1.
     

     >> Share

     
     December 2021
305. TIAN F, Song W, Wang L, Zeng Q, et al
     NT-pro BNP in AECOPD-PH: old biomarker, new insights-based on a large retrospective case-controlled study.
     Respir Res. 2021;22:321.
     

     >> Share

     
     
306. MCKENZIE J, Nisha P, Cannon-Bailey S, Cain C, et al
     Overnight variation in tidal expiratory flow limitation in COPD patients and its correction: an observational study.
     Respir Res. 2021;22:319.
     

     >> Share

     
     
307. HERNANDEZ CORDERO AI, Yang CX, Li X, Milne S, et al
     Epigenetic marker of telomeric age is associated with exacerbations and hospitalizations in chronic obstructive pulmonary disease.
     Respir Res. 2021;22:316.
     

     >> Share

     
     
308. SKIBBA ME, Xu X, Weiss K, Huisken J, et al
     Role of Secretoglobin(+) (club cell) NFkappaB/RelA-TGFbeta signaling in aero-allergen-induced epithelial plasticity and subepithelial myofibroblast transdifferentiation.
     Respir Res. 2021;22:315.
     

     >> Share

     
     
309. MASPERO J, Agache IO, Kamei T, Yoshida M, et al
     Long-term safety and exploratory efficacy of fevipiprant in patients with inadequately controlled asthma: the SPIRIT randomised clinical trial.
     Respir Res. 2021;22:311.
     

     >> Share

     
     
310. BURBANK AJ, Schworer SA, Sood A, Almond M, et al
     Airway IL-1beta associates with IL-5 production following dust mite allergen inhalation in humans.
     Respir Res. 2021;22:309.
     

     >> Share

     
     November 2021
311. KOSHY K, Sha J, Bennetts K, Langton D, et al
     Safety of delivering bronchial thermoplasty in two treatment sessions.
     Respir Res. 2021;22:307.
     

     >> Share

     
     
312. CUI Y, Zhang W, Ma Y, Zhan Z, et al
     Stability of blood eosinophils in acute exacerbation of chronic obstructive pulmonary disease and its relationship to clinical outcomes: a prospective cohort study.
     Respir Res. 2021;22:301.
     

     >> Share

     
     
313. JOO DH, Lee KH, Lee CH, Woo J, et al
     Developmental endothelial locus-1 as a potential biomarker for the incidence of acute exacerbation in patients with chronic obstructive pulmonary disease.
     Respir Res. 2021;22:297.
     

     >> Share

     
     
314. SCHMIDT J, Martin A, Wenzel C, Weber J, et al
     Control of the expiratory flow in a lung model and in healthy volunteers with an adjustable flow regulator: a combined bench and randomized crossover study.
     Respir Res. 2021;22:292.
     

     >> Share

     
     
315. SVERRILD A, Leadbetter J, Porsbjerg C
     The use of the mannitol test as an outcome measure in asthma intervention studies: a review and practical recommendations.
     Respir Res. 2021;22:287.
     

     >> Share

     
     
316. SU X, Chen J, Lin X, Chen X, et al
     FERMT3 mediates cigarette smoke-induced epithelial-mesenchymal transition through Wnt/beta-catenin signaling.
     Respir Res. 2021;22:286.
     

     >> Share

     
     October 2021
317. VOGELMEIER CF, Jones PW, Kerwin EM, Boucot IH, et al
     Efficacy of umeclidinium/vilanterol according to the degree of reversibility of airflow limitation at screening: a post hoc analysis of the EMAX trial.
     Respir Res. 2021;22:279.
     

     >> Share

     
     
318. HARDING JN, Gross M, Patel V, Potter S, et al
     Association between particulate matter containing EPFRs and neutrophilic asthma through AhR and Th17.
     Respir Res. 2021;22:275.
     

     >> Share

     
     
319. YOSHIZAKI A, Nagano T, Izumi S, Nishiuma T, et al
     Characteristics of the nocturnal desaturation waveform pattern of SpO2 in COPD patients: an observational study.
     Respir Res. 2021;22:276.
     

     >> Share

     
     
320. NG J, Pacheco-Rodriguez G, Begley L, Huang YJ, et al
     The lung microbiome in end-stage Lymphangioleiomyomatosis.
     Respir Res. 2021;22:277.
     

     >> Share

     
     
321. LI N, Dai Z, Wang Z, Deng Z, et al
     Gut microbiota dysbiosis contributes to the development of chronic obstructive pulmonary disease.
     Respir Res. 2021;22:274.
     

     >> Share

     
     
322. CHAPMAN KR, Wise RA, Scirica BM, Bhatt DL, et al
     Long-acting antimuscarinic therapy in patients with chronic obstructive pulmonary disease receiving beta-blockers.
     Respir Res. 2021;22:272.
     

     >> Share

     
     
323. SHIRAISHI M, Higashimoto Y, Sugiya R, Mizusawa H, et al
     Diaphragmatic excursion is correlated with the improvement in exercise tolerance after pulmonary rehabilitation in patients with chronic obstructive pulmonary disease.
     Respir Res. 2021;22:271.
     

     >> Share

     
     
324. TUPPER OD, Ulrik CS
     Long-term predictors of severe exacerbations and mortality in a cohort of well-characterised adults with asthma.
     Respir Res. 2021;22:269.
     

     >> Share

     
     
325. QIU M, Jiang J, Nian X, Wang Y, et al
     Factors associated with mortality in rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis.
     Respir Res. 2021;22:264.
     

     >> Share

     
     
326. CARSTENSEN S, Gress C, Erpenbeck VJ, Kazani SD, et al
     Prostaglandin D2 metabolites activate asthmatic patient-derived type 2 innate lymphoid cells and eosinophils via the DP2 receptor.
     Respir Res. 2021;22:262.
     

     >> Share

     
     
327. USMANI O, Roche N, Wahab E, Israel S, et al
     A scintigraphy study of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in patients with moderate-to-very severe chronic obstructive pulmonary disease.
     Respir Res. 2021;22:261.
     

     >> Share

     
     
328. CARL J, Schultz K, Janssens T, von Leupoldt A, et al
     The "can do, do do" concept in individuals with chronic obstructive pulmonary disease: an exploration of psychological mechanisms.
     Respir Res. 2021;22:260.
     

     >> Share

     
     August 2021
329. HUBER MB, Schneider N, Kirsch F, Schwarzkopf L, et al
     Long-term weight gain in obese COPD patients participating in a disease management program: a risk factor for reduced health-related quality of life.
     Respir Res. 2021;22:226.
     

     >> Share

     
     
330. VOGT S, Leuppi JD, Schuetz P, Mueller B, et al
     Association of mannose-binding lectin, ficolin-2 and immunoglobulin concentrations with future exacerbations in patients with chronic obstructive pulmonary disease: secondary analysis of the randomized controlled REDUCE trial.
     Respir Res. 2021;22:227.
     

     >> Share

     
     
331. HSU HT, Wu CD, Chung MC, Shen TC, et al
     The effects of traffic-related air pollutants on chronic obstructive pulmonary disease in the community-based general population.
     Respir Res. 2021;22:217.
     

     >> Share

     
     July 2021
332. LONG H, Xu H, Janssens JP, Guo Y, et al
     Single-inhaler triple vs single-inhaler dual therapy in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized control trials.
     Respir Res. 2021;22:209.
     

     >> Share

     
     
333. PU X, Liu L, Feng B, Zhang Z, et al
     Association between ICS use and risk of hyperglycemia in COPD patients: systematic review and meta-analysis.
     Respir Res. 2021;22:201.
     

     >> Share

     
     
334. HARBAUM L, Hennigs JK, Simon M, Oqueka T, et al
     Genetic evidence for a causative effect of airflow obstruction on left ventricular filling: a Mendelian randomisation study.
     Respir Res. 2021;22:199.
     

     >> Share

     
     
335. VAN DEN BERGE M, De Backer J, Van Holsbeke C, De Backer W, et al
     Functional respiratory imaging assessment of budesonide/glycopyrrolate/formoterol fumarate and glycopyrrolate/formoterol fumarate metered dose inhalers in patients with COPD: the value of inhaled corticosteroids.
     Respir Res. 2021;22:191.
     

     >> Share

     
     
336. ZHU J, Wang F, Feng X, Li B, et al
     Family with sequence similarity 13 member A mediates TGF-beta1-induced EMT in small airway epithelium of patients with chronic obstructive pulmonary disease.
     Respir Res. 2021;22:192.
     

     >> Share

     
     June 2021
337. MURO S, Sugiura H, Darken P, Dorinsky P, et al
     Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts.
     Respir Res. 2021;22:187.
     

     >> Share

     
     
338. KOARAI A, Yamada M, Ichikawa T, Fujino N, et al
     Triple versus LAMA/LABA combination therapy for patients with COPD: a systematic review and meta-analysis.
     Respir Res. 2021;22:183.
     

     >> Share

     
     
339. MURO S, Suzuki M, Nakamura S, Wang JR, et al
     Real-world effectiveness of early intervention with fixed-dose tiotropium/olodaterol vs tiotropium in Japanese patients with COPD: a high-dimensional propensity score-matched cohort analysis.
     Respir Res. 2021;22:180.
     

     >> Share

     
     
340. GU Y, Ye X, Liu Y, Wang Y, et al
     A risk-predictive model for invasive pulmonary aspergillosis in patients with acute exacerbation of chronic obstructive pulmonary disease.
     Respir Res. 2021;22:176.
     

     >> Share

     
     
341. ANDELID K, Ost K, Andersson A, Mohamed E, et al
     Lung macrophages drive mucus production and steroid-resistant inflammation in chronic bronchitis.
     Respir Res. 2021;22:172.
     

     >> Share

     
     May 2021
342. SIVAPALAN P, Rutishauser J, Ulrik CS, Leuppi JD, et al
     Effect of different corticosteroid regimes for hospitalised patients with exacerbated COPD: pooled analysis of individual participant data from the REDUCE and CORTICO-COP trials.
     Respir Res. 2021;22:155.
     

     >> Share

     
     
343. ZHENG ZG, Sun WZ, Hu JY, Jie ZJ, et al
     Hydrogen/oxygen therapy for the treatment of an acute exacerbation of chronic obstructive pulmonary disease: results of a multicenter, randomized, double-blind, parallel-group controlled trial.
     Respir Res. 2021;22:149.
     

     >> Share

     
     
344. JACOBSEN PA, van 't Hul AJ, Djamin RS, Antons JC, et al
     Characteristics and treatable traits of patients with chronic obstructive pulmonary disease (COPD) with and without paid employment.
     Respir Res. 2021;22:147.
     

     >> Share

     
     
345. WEISS DJ, Segal K, Casaburi R, Hayes J, et al
     Effect of mesenchymal stromal cell infusions on lung function in COPD patients with high CRP levels.
     Respir Res. 2021;22:142.
     

     >> Share

     
     
346. GLOECKL R, Schneeberger T, Leitl D, Reinold T, et al
     Whole-body vibration training versus conventional balance training in patients with severe COPD-a randomized, controlled trial.
     Respir Res. 2021;22:138.
     

     >> Share

     
     April 2021
347. HEALY C, Munoz-Wolf N, Strydom J, Faherty L, et al
     Nutritional immunity: the impact of metals on lung immune cells and the airway microbiome during chronic respiratory disease.
     Respir Res. 2021;22:133.
     

     >> Share

     
     
348. SINGH D, Criner GJ, Dransfield MT, Halpin DMG, et al
     InforMing the PAthway of COPD Treatment (IMPACT) trial: fibrinogen levels predict risk of moderate or severe exacerbations.
     Respir Res. 2021;22:130.
     

     >> Share

     
     
349. PRATTE KA, Curtis JL, Kechris K, Couper D, et al
     Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD.
     Respir Res. 2021;22:127.
     

     >> Share

     
     
350. MAJORSKI DS, Magnet FS, Thilemann S, Schmoor C, et al
     Portable NIV for patients with moderate to severe COPD: two randomized crossover trials.
     Respir Res. 2021;22:123.
     

     >> Share

     
     
351. ZHANG WZ, Hoffman KL, Schiffer KT, Oromendia C, et al
     Association of plasma mitochondrial DNA with COPD severity and progression in the SPIROMICS cohort.
     Respir Res. 2021;22:126.
     

     >> Share

     
     
352. SINGH R, Belchamber KBR, Fenwick PS, Chana K, et al
     Defective monocyte-derived macrophage phagocytosis is associated with exacerbation frequency in COPD.
     Respir Res. 2021;22:113.
     

     >> Share

     
     
353. KIM V, Dolliver WR, Nath HP, Grumley SA, et al
     Mucus plugging on computed tomography and chronic bronchitis in chronic obstructive pulmonary disease.
     Respir Res. 2021;22:110.
     

     >> Share

     
     
354. LI X, Noell G, Tabib T, Gregory AD, et al
     Single cell RNA sequencing identifies IGFBP5 and QKI as ciliated epithelial cell genes associated with severe COPD.
     Respir Res. 2021;22:100.
     

     >> Share

     
     March 2021
355. CHUBACHI S, Yamada Y, Yamada M, Yokoyama Y, et al
     Differences in airway lumen area between supine and upright computed tomography in patients with chronic obstructive pulmonary disease.
     Respir Res. 2021;22:95.
     

     >> Share

     
     
356. MACHADO FVC, Spruit MA, Groenen MTJ, Houben-Wilke S, et al
     Frequency and functional translation of low muscle mass in overweight and obese patients with COPD.
     Respir Res. 2021;22:93.
     

     >> Share

     
     
357. PAN K, Lu J, Song Y
     Artesunate ameliorates cigarette smoke-induced airway remodelling via PPAR-gamma/TGF-beta1/Smad2/3 signalling pathway.
     Respir Res. 2021;22:91.
     

     >> Share

     
     
358. ZHENG J, Baldi S, Zhao L, Li H, et al
     Efficacy and safety of single-inhaler extrafine triple therapy versus inhaled corticosteroid plus long-acting beta2 agonist in eastern Asian patients with COPD: the TRIVERSYTI randomised controlled trial.
     Respir Res. 2021;22:90.
     

     >> Share

     
     
359. PARK HJ, Kim SR, Kim S, Lee HS, et al
     Influence of government-driven quality assessment program on patients with chronic obstructive pulmonary disease.
     Respir Res. 2021;22:87.
     

     >> Share

     
     
360. SERRE J, Tanjeko AT, Mathyssen C, Vanherwegen AS, et al
     Enhanced lung inflammatory response in whole-body compared to nose-only cigarette smoke-exposed mice.
     Respir Res. 2021;22:86.
     

     >> Share

     
     
361. BLERVAQUE L, Prefaut C, Forthin H, Maffre F, et al
     Efficacy of a long-term pulmonary rehabilitation maintenance program for COPD patients in a real-life setting: a 5-year cohort study.
     Respir Res. 2021;22:79.
     

     >> Share

     
     
362. CAO Y, Xing Z, Long H, Huang Y, et al
     Predictors of mortality in COPD exacerbation cases presenting to the respiratory intensive care unit.
     Respir Res. 2021;22:77.
     

     >> Share

     
     February 2021
363. PEROTIN JM, Polette M, Deslee G, Dormoy V, et al
     CiliOPD: a ciliopathy-associated COPD endotype.
     Respir Res. 2021;22:74.
     

     >> Share

     
     
364. LI LY, Yan TS, Yang J, Li YQ, et al
     Impulse oscillometry for detection of small airway dysfunction in subjects with chronic respiratory symptoms and preserved pulmonary function.
     Respir Res. 2021;22:68.
     

     >> Share

     
     
365. MALVISI L, Taddei L, Yarraguntla A, Wilkinson TMA, et al
     Sputum sample positivity for Haemophilus influenzae or Moraxella catarrhalis in acute exacerbations of chronic obstructive pulmonary disease: evaluation of association with positivity at earlier stable disease timepoints.
     Respir Res. 2021;22:67.
     

     >> Share

     
     
366. GULEA C, Zakeri R, Alderman V, Morgan A, et al
     Beta-blocker therapy in patients with COPD: a systematic literature review and meta-analysis with multiple treatment comparison.
     Respir Res. 2021;22:64.
     

     >> Share

     
     
367. YANG N, Singhera GK, Yan YX, Pieper MP, et al
     Olodaterol exerts anti-inflammatory effects on COPD airway epithelial cells.
     Respir Res. 2021;22:65.
     

     >> Share

     
     
368. PISON C, Shah PL, Slebos DJ, Ninane V, et al
     Safety of denervation following targeted lung denervation therapy for COPD: AIRFLOW-1 3-year outcomes.
     Respir Res. 2021;22:62.
     

     >> Share

     
     
369. SAITO T, Ichikawa T, Numakura T, Yamada M, et al
     PGC-1alpha regulates airway epithelial barrier dysfunction induced by house dust mite.
     Respir Res. 2021;22:63.
     

     >> Share

     
     
370. CHEN W, Sadatsafavi M, FitzGerald JM, Lynd LD, et al
     Gender modifies the effect of body mass index on lung function decline in mild-to-moderate COPD patients: a pooled analysis.
     Respir Res. 2021;22:59.
     

     >> Share

     
     
371. CORDOBA-LANUS E, Cazorla-Rivero S, Garcia-Bello MA, Mayato D, et al
     Telomere length dynamics over 10-years and related outcomes in patients with COPD.
     Respir Res. 2021;22:56.
     

     >> Share

     
     
372. SAVRAN O, Godtfredsen N, Sorensen T, Jensen C, et al
     COPD patients prescribed inhaled corticosteroid in primary care: time for re-assessment based on exacerbation rate and blood eosinophils?
     Respir Res. 2021;22:54.
     

     >> Share

     
     
373. KANG J, Lee JS, Lee SW, Lee JB, et al
     Dual versus monotherapy with bronchodilators in GOLD group B COPD patients according to baseline FEV1 level: a patient-level pooled analysis of phase-3 randomized clinical trials.
     Respir Res. 2021;22:55.
     

     >> Share

     
     
374. VAN DEN BERG MPM, Nijboer-Brinksma S, Bos IST, van den Berge M, et al
     The novel TRPA1 antagonist BI01305834 inhibits ovalbumin-induced bronchoconstriction in guinea pigs.
     Respir Res. 2021;22:48.
     

     >> Share

     
     
375. WANG Y, Liao K, Liu B, Niu C, et al
     GITRL on dendritic cells aggravates house dust mite-induced airway inflammation and airway hyperresponsiveness by modulating CD4(+) T cell differentiation.
     Respir Res. 2021;22:46.
     

     >> Share

     
     
376. KIM J, Kim B, Bak SH, Oh YM, et al
     A comparative study of chest CT findings regarding the effects of regional dust exposure on patients with COPD living in urban areas and rural areas near cement plants.
     Respir Res. 2021;22:43.
     

     >> Share

     
     
377. SONG Q, Chen P, Liu XM
     The role of cigarette smoke-induced pulmonary vascular endothelial cell apoptosis in COPD.
     Respir Res. 2021;22:39.
     

     >> Share

     
     
378. CALLE RUBIO M, Rodriguez Hermosa JL, de Torres JP, Marin JM, et al
     COPD Clinical Control: predictors and long-term follow-up of the CHAIN cohort.
     Respir Res. 2021;22:36.
     

     >> Share

     
     
379. GALDI F, Pedone C, McGee CA, George M, et al
     Inhaled high molecular weight hyaluronan ameliorates respiratory failure in acute COPD exacerbation: a pilot study.
     Respir Res. 2021;22:30.
     

     >> Share

     
     January 2021
380. LEMAIRE F, Audonnet S, Perotin JM, Gaudry P, et al
     The elastin peptide VGVAPG increases CD4(+) T-cell IL-4 production in patients with chronic obstructive pulmonary disease.
     Respir Res. 2021;22:14.
     

     >> Share

     
     
381. BAGGE K, Sivapalan P, Eklof J, Hertz FB, et al
     Antibiotic treatment in acute exacerbation of COPD: patient outcomes with amoxicillin vs. amoxicillin/clavulanic acid-data from 43,636 outpatients.
     Respir Res. 2021;22:11.
     

     >> Share

     
     
382. MAO X, Liang C, Niu H, Dong F, et al
     Outcomes associated with comorbid diabetes among patients with COPD exacerbation: findings from the ACURE registry.
     Respir Res. 2021;22:7.
     

     >> Share

     
     

Free Medical Abstracts
Privacy Policy
Sponsors
Share